UGIF
CLB icon

US Global Investors Funds’s Core Laboratories CLB Stock Holding History

US Global Investors Funds’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$573K Buy
+3,000
New +$558K 0.1% 164

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

US Global Investors Funds's CLB Position: Q4 2013 in Review

US Global Investors Funds opened a new position in Core Laboratories (CLB) in Q4 2013: 3,000 shares worth $573K. The stake represents 0.1% of the portfolio and ranks #164 among its holdings.

345 funds tracked by Wall St. Rank hold CLB as of Q4 2013.

  • US Global Investors Funds held 3,000 shares of Core Laboratories worth $573K as of Q4 2013.
  • Core Laboratories was a new US Global Investors Funds position in Q4 2013.
  • Core Laboratories made up 0.1% of US Global Investors Funds's portfolio in Q4 2013, its #164 holding.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2013.

Based on US Global Investors Funds's 13F filing for Q4 2013, filed 18 Feb 2014.